Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
International Journal of Cardiology|June 15, 2010
Screening for overt diabetes by oral glucose tolerance test: stratification by fasting blood glucose and patients' age improve practicability of guidelines in cardiological routineKerstin Kempf, Reiner Füth, Wilfried Dinh, et al.Cardiovascular Diabetology|April 1, 2021
Report from the CVOT Summit 2020: new cardiovascular and renal outcomesOliver Schnell, Xavier Cos, Francesco Cosentino, et al.Diabetes Technology & Therapeutics|June 3, 2005
IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study designAndreas Pfützner, Eberhard Standl, Cloth Hohberg, et al.Acta Diabetologica|June 23, 2009
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?Dario Giugliano, Eberhard Standl, Tina Vilsbøll, et al.Diabetes Research and Clinical Practice|October 9, 2020
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trialMalgorzata Wamil, John J V McMurray, Charles A B Scott, et al.Cardiovascular Diabetology|August 27, 2022
Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular diseaseSusanna R Stevens, Matthew W Segar, Ambarish Pandey, et al.Diabetes Care|August 2, 2007
Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)Erland Erdmann, Bernard Charbonnel, Robert G Wilcox, et al.Diabetes, Obesity & Metabolism|February 7, 2018
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)Timothy M E Davis, Hillary Mulder, Yuliya Lokhnygina, et al.Cardiovascular Diabetology|November 6, 2021
Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and managementAntonio Ceriello, Doina Catrinoiu, Chanchal Chandramouli, et al.Diabetes Care|December 29, 2019
Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCELEberhard Standl, Susanna R Stevens, Yuliya Lokhnygina, et al.Pageof 10